Alnylam Pharmaceuticals I...

268.50
-2.52 (-0.93%)
At close: Mar 28, 2025, 3:59 PM
266.00
-0.93%
After-hours: Mar 28, 2025, 07:58 PM EDT

Alnylam Pharmaceuticals Revenue

Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending December 31, 2024, Alnylam Pharmaceuticals generated $593.17M in revenue.
Revenue (ttm)
$2.25B
Revenue Growth
22.97%
Price / Sales Ratio
13.46
Revenue / Employee
$1.01M
Employees
2,230
Market Cap
34.92B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 2.25B +22.97%
Dec 31, 2023 1.83B +76.23%
Dec 31, 2022 1.04B +22.88%
Dec 31, 2021 844.29M +71.31%
Dec 31, 2020 492.85M n/a